Influenza and ARVI: challenges and solutions
ARVI and influenza are one of the topical problems of pediatrics, which is due to the high level of morbidity in the child population, a significant incidence of severe and complicated forms of disease, especially in young children. In the structure of infectious pathology in children, this group of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2019-02-01
|
| Series: | Медицинский совет |
| Online Access: | https://www.med-sovet.pro/jour/article/view/2855 |
| _version_ | 1797841424585064448 |
|---|---|
| author | Article Editorial |
| author_facet | Article Editorial |
| author_sort | Article Editorial |
| collection | DOAJ |
| description | ARVI and influenza are one of the topical problems of pediatrics, which is due to the high level of morbidity in the child population, a significant incidence of severe and complicated forms of disease, especially in young children. In the structure of infectious pathology in children, this group of diseases still retains its leading position, accounting for up to 70% of all registered cases. Almost every child annually and more than once endures ARVI or flu episodes. This group of infections causes significant economic damage both to the household budget and the national budget as a whole. In order to improve the provision of medical care for children, improve the qualifications of pediatricians and share experience of the Department of Pediatrics named after Academician G.N. Speranskiy RMACPE (Head of Department Dr. of Sci. (Med), Professor I.N. Zakharova), a scientific and practical seminar «Influenza and acute respiratory infections 2018/2019: challenges and solutions» was held. Within the framework of the event, supported by «Valenta Pharm», specialists considered a number of topical issues, including vaccine prophylaxis and treatment of ARVI and influenza, taking into account modern epidemiological, microbiological and virological data. The seminar participants paid special attention to the validity of antiviral therapy in children, in particular, such drug as Ingavirin®. |
| first_indexed | 2024-04-09T16:30:35Z |
| format | Article |
| id | doaj.art-4ffef8f15f0b4a8ab350c7837e3ff3e1 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:30:35Z |
| publishDate | 2019-02-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-4ffef8f15f0b4a8ab350c7837e3ff3e12023-04-23T06:57:06ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902019-02-0102687510.21518/2079-701X-2019-2-68-752786Influenza and ARVI: challenges and solutionsArticle EditorialARVI and influenza are one of the topical problems of pediatrics, which is due to the high level of morbidity in the child population, a significant incidence of severe and complicated forms of disease, especially in young children. In the structure of infectious pathology in children, this group of diseases still retains its leading position, accounting for up to 70% of all registered cases. Almost every child annually and more than once endures ARVI or flu episodes. This group of infections causes significant economic damage both to the household budget and the national budget as a whole. In order to improve the provision of medical care for children, improve the qualifications of pediatricians and share experience of the Department of Pediatrics named after Academician G.N. Speranskiy RMACPE (Head of Department Dr. of Sci. (Med), Professor I.N. Zakharova), a scientific and practical seminar «Influenza and acute respiratory infections 2018/2019: challenges and solutions» was held. Within the framework of the event, supported by «Valenta Pharm», specialists considered a number of topical issues, including vaccine prophylaxis and treatment of ARVI and influenza, taking into account modern epidemiological, microbiological and virological data. The seminar participants paid special attention to the validity of antiviral therapy in children, in particular, such drug as Ingavirin®.https://www.med-sovet.pro/jour/article/view/2855 |
| spellingShingle | Article Editorial Influenza and ARVI: challenges and solutions Медицинский совет |
| title | Influenza and ARVI: challenges and solutions |
| title_full | Influenza and ARVI: challenges and solutions |
| title_fullStr | Influenza and ARVI: challenges and solutions |
| title_full_unstemmed | Influenza and ARVI: challenges and solutions |
| title_short | Influenza and ARVI: challenges and solutions |
| title_sort | influenza and arvi challenges and solutions |
| url | https://www.med-sovet.pro/jour/article/view/2855 |
| work_keys_str_mv | AT articleeditorial influenzaandarvichallengesandsolutions |